<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-pharmaceuticals-10-00084">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Greig</surname>
    <given-names>N.H.</given-names>
   </name>
   <name>
    <surname>Utsuki</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ingram</surname>
    <given-names>D.K.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Pepeu</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Scali</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>Q.S.</given-names>
   </name>
   <name>
    <surname>Mamczarz</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Holloway</surname>
    <given-names>H.W.</given-names>
   </name>
   <name>
    <surname>Giordano</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer Î²-amyloid peptide in rodent</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2005</year>
  <volume>102</volume>
  <fpage>17213</fpage>
  <lpage>17218</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.0508575102</pub-id>
  <?supplied-pmid 16275899?>
  <pub-id pub-id-type="pmid">16275899</pub-id>
 </element-citation>
</ref>
